fda compounded semaglutide ban Novo Nordisk asks to Ozempic, Wegovy copies Despite FDA ruling, compounded GLP-1s

Interestingly, patients on these drugs in both studies actually had fewer severe vision problems from diabetic retinopathy and needed fewer invasive eye treatments than those on other diabetes medicines

GLP-1 receptor agonists are synthetic analogs or modified versions of this endogenous hormone, designed to resist degradation by the enzyme dipeptidyl peptidase-4 (DPP-4), thereby extending their duration of action from minutes to hours or days

On the other hand, just months ago, Roche licensed an amylin-related pipeline in a deal worth $5.3 billion

adults were taking GLP-1 medications as of November to lose weight or treat a chronic condition like diabetes, according to a study by the Kaiser Family Foundation

GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction

Olfactory dysfunction, including parosmia, has been associated with liraglutide use 46 , likely reflecting GLP-1R-mediated modulation of odor-evoked insulin secretion and foraging behaviors in the olfactory bulb 51,52